Jacques Turgeon
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Pharmacology 71
- Pharmacogenetics and Drug Metabolism 66
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Pharmaceutical Practices and Patient Outcomes 24
- Co-authors
- Véronique MichaudPascal DaleauBettina A. HamelinBenoît DroletM. R. GilbertÉtienne LessardO Grech-BélangerGilles O’Hara
- Journals
- Clinical Pharmacology & Therapeutics (14 papers)Journal of Pharmacology and Experimental Therapeutics (10 papers)Pharmaceutics (7 papers)British Journal of Clinical Pharmacology (7 papers)Therapeutic Drug Monitoring (6 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Jacques Turgeon
184 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 136
- Pharmacology 1.5k
- Geriatrics and Gerontology 356
- Cardiology and Cardiovascular Medicine 1.5k
- Pharmacology 703
- Family Practice 85
Countries citing papers authored by Jacques Turgeon
This map shows the geographic impact of Jacques Turgeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Turgeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Turgeon more than expected).
Fields of papers citing papers by Jacques Turgeon
This network shows the impact of papers produced by Jacques Turgeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Turgeon. The network helps show where Jacques Turgeon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques Turgeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 36 | |
| 6 | Mechanisms and Clinical Relevance of Drug-Induced Long QT Syndrome: Block of hERG, Drug Metabolism and Drug Transport in the Human Heart | 2020 | 3 |
| 7 | 2020 | 10 | |
| 8 | 2019 | 13 | |
| 9 | 2017 | 14 | |
| 10 | 2015 | 6 | |
| 11 | 2012 | 8 | |
| 12 | 2011 | 27 | |
| 13 | 2010 | 60 | |
| 14 | 2009 | 7 | |
| 15 | 2008 | 45 | |
| 16 | 2006 | 93 | |
| 17 | 2006 | 49 | |
| 18 | 2001 | 98 | |
| 19 | 2001 | 14 | |
| 20 | 1998 | 33 |
About Jacques Turgeon
Jacques Turgeon is a scholar working on Pharmacology, Geriatrics and Gerontology, Family Practice, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 187 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (66 papers), Cardiac electrophysiology and arrhythmias (41 papers), Ion channel regulation and function (28 papers), Pharmaceutical Practices and Patient Outcomes (24 papers), Analytical Methods in Pharmaceuticals (20 papers), Drug Transport and Resistance Mechanisms (17 papers), Analytical Chemistry and Chromatography (16 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). The work is most often cited by research in Pharmacology (1.5k citations), Geriatrics and Gerontology (356 citations), Cardiology and Cardiovascular Medicine (1.5k citations), Pharmacology (703 citations) and Family Practice (85 citations). Jacques Turgeon has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Véronique Michaud, Pascal Daleau, Bettina A. Hamelin, Benoît Drolet, M. R. Gilbert, Étienne Lessard, O Grech-Bélanger, Gilles O’Hara, Malavika Deodhar and Sweilem B. Al Rihani. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmacology and Experimental Therapeutics, Pharmaceutics, British Journal of Clinical Pharmacology and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.